Javascript Menu by Deluxe-Menu.com

Advanced Search
  Home Breaking News Newsletters Books & Reports Events Jobs Advisory Board Interviews e-Alert Contact Us
Diagnostic Imaging & Intelligence   •   G2 Compliance   •   Laboratory Industry   •   National Intelligence   •   Diagnostic Testing & Technology  
     
 
Laboratory Industry Report

Lab Industry Awaits First Domino of Competitive Bidding Project to Tip
January 2007


Main Article

Sidebar: Competitive Bidding Structure
BackBack

“Not much is going to happen until we have that first domino of OMB approval. After we get OMB approval on the key design elements, we’ll announce demonstration sites, we’ll hold an open-door forum, and then another open-door forum to ask questions about implementation.”

“Everybody has come together and looked at this and recognized that you can’t commoditize clinical laboratory medicine service,” says ACLA’s David Mongillo. “It’s just a tremendously flawed system if they move ahead with this demonstration project.”

Sidebar: Competitive Bidding Structure

  • There will be two demonstration sites. The demos will last three years and will have staggered starts.
  • The sites will be chosen based on the beneficiaries who live within comp-etitive bidding areas (CBAs) and not based on a laboratory’s location.
  • The project excludes hospital inpatient and outpatient testing, as well as physician office lab (POL) testing.
  • The project will include tests offered by independent labs, as well as nonpatient testing by hospitals and POLs.
  • The project will cover all laboratory tests paid for under Medicare Part B clinical lab fee schedule with the exception of Pap smears, colorectal cancer screening tests, and new tests added to the lab fee schedule during the course of the demonstration.
  • Laboratories that have more than $100,000 in annual Medicare test payments in CBA are required to bid.
  • Laboratories that have less than $100,000 in demo test annual payments are not required to bid, but will be paid for demo tests provided to beneficiaries residing in the CBA at the competitively bid fee schedule. Annual payments are capitated.
  • Labs that participate in bidding but do not win will not be eligible for Medicare reimbursement for demo tests provided to beneficiaries residing in the CBA.
  • Laboratories that are required to bid but do not participate in the bidding will be ineligible for Medicare Part B reimbursement for demo tests provided to beneficiaries residing in the CBA.
  • Winning laboratories will be paid under one competitively set demonstration Medicare Part B clinical laboratory fee schedule for lab tests provided to beneficiaries living in the demo area.

   

 

Archives

 
     
  Home Privacy Awards & Scholarships Advisory Board Contact Us Advertising Blogs & Online Resources List Rentals

Copyright © 1999-2008 Washington G-2 Reports. No portion of the material presented on this site may be used without express written permission from authorized personnel at Washington G-2 Reports. Washington G-2 Reports is an operating unit of IOMA, the Institute of Management & Administration, Inc.